Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional versus systemic dexmedetomidine as an adjuvant to lidocaine for intravenous regional anesthesia
ChiCTR2300067978Phase 4Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Tourniquet tolerance time. Started Feb 2023; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR2300067978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067978.